IPO Trending
MANKINDEQ / NSE, BSEListed

Mankind Pharma Limited

Incorporated in 1991, Mankind Pharma Limited develops, manufactures, and markets pharmaceutical formulations and consumer healthcare products across a wide range of acute and chronic therapeutic areas in India, including anti-infectives, cardiovascular, gastrointestinal, anti-diabetic, neuro/CNS, vitamins/minerals/nutrients, and respiratory. The company offers over 36 brands such as Manforce, Moxikind-CV, Amlokind-AT, Prega News, and Gudcef, supported by one of the largest distribution networks of medical representatives in India, with over 80% of doctors prescribing its formulations. Ranked 4th in domestic sales in FY2022, Mankind Pharma has received numerous awards, including The Best of Bharat Awards 2022, National Awards for Manufacturing Competitiveness Silver Medal 2021, and recognition for Best Design in Healthcare and performance management excellence.

₹1,026 - ₹1,08015.32x sub
Listed Price1300.00
Listing Gain+20.37%
AllotmentRegistrar: KFin Technologies Limited
Allotment Date2023-05-04
Official StatusN/A

Status Checker

Link Your Depository Accounts

Authenticate with your mobile number to view saved PAN cards, run automatic sequential allotment checks, and track allocation outcomes instantly.

or check manually
⚡ Quick Simulator Test
Official Status Portal